Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Camostat
2. Camostat Mesilate
3. Camostate
4. Camostate-mesilate
5. Foipan
6. Foy 305
7. Foy S 980
8. Foy-305
9. Foypan
10. N,n-dimethylcarbamoylmethyl-4-(4-guanidinobenzoyloxy)phenylacetate Methanesulfonate
11. P-guanidinobenzoic Acid, Ester With (p-hydroxyphenyl)acetic Acid, Ester With N,n-dimethylglycolamide
1. Camostat Mesilate
2. 59721-29-8
3. Camostat (mesylate)
4. Camostat Methanesulfonate
5. Foipan
6. Camostate
7. Mfcd00941410
8. Foy305
9. Camostat Mesilate [jan]
10. Camostat Mesilate;foy305;foy-s980
11. Dsstox_cid_238
12. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate Methanesulfonate
13. Dsstox_rid_75452
14. Dsstox_gsid_20238
15. Chembl85164
16. 2-(dimethylamino)-2-oxoethyl 4-(4-guanidinobenzoyloxy)phenylacetate Methanesulphonate
17. Methanesulfonic Acid 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate
18. 451m50a1eq
19. Cas-59721-29-8
20. Ncgc00167526-01
21. Foy-305
22. Foipan (tn)
23. Camostat Mesylate- Bio-x
24. Camostat Mesilate (jp17)
25. Mls006010697
26. Schembl871583
27. Foy-s980
28. Camostat Mesilate (foy-305)
29. Dtxsid0020238
30. Chebi:31347
31. Amy8832
32. Camostat Mesilate [mart.]
33. Hms3651d04
34. Camostat Mesilate [who-dd]
35. Bcp06708
36. Ex-a4154
37. Tox21_112523
38. Camostat Mesylate, >=98% (hplc)
39. S2874
40. Camostat Methanesulfonate [mi]
41. Akos015966692
42. Akos026750463
43. Tox21_112523_1
44. Ac-8540
45. Ccg-269652
46. Hs-0060
47. Ncgc00167526-02
48. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-((diaminomethylene)amino)benzoate Methanesulfonate
49. 4-[[4-[(aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid 2-(dimethylamino)-2-oxoethyl Ester Methanesulfonate
50. Bc164270
51. Hy-13512
52. Smr002530343
53. Sy060177
54. Db-072684
55. B2082
56. Ft-0648873
57. Sw219517-1
58. D01766
59. F20649
60. 721c298
61. A832436
62. Q-200778
63. Q23731028
64. 4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl4-guanidinobenzoatemethanesulfonate
65. 4-(2-{[2-(dimethylamino)-2-oxoethyl]oxy}-2-oxoethyl)phenyl 4-{[amino(imino)methyl]amino}benzoate Methanesulfonate
66. 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-[(diaminomethylidene)amino]benzoate; Methanesulfonic Acid
Molecular Weight | 494.5 g/mol |
---|---|
Molecular Formula | C21H26N4O8S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 9 |
Exact Mass | 494.14713497 g/mol |
Monoisotopic Mass | 494.14713497 g/mol |
Topological Polar Surface Area | 200 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 695 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Trypsin Inhibitors
Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)
Registration Number : 229MF10164
Registrant's Address : VIA F. BARACCA 19-24060 SAN PAOLO D'ARGON (BERGAMO) ITALY
Initial Date of Registration : 2017-08-22
Latest Date of Registration : 2024-11-20
Camostat mesilate (for manufacturing only)
Registration Number : 221MF10058
Registrant's Address : 55 Yokohoonji, Kamiichi-cho, Nakaniikawa-gun, Toyama Prefecture
Initial Date of Registration : 2009-03-19
Latest Date of Registration : 2009-03-19
Japanese Pharmacopoeia Camostat Mesilate (for manufacturing only)
Registration Number : 219MF10222
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2007-07-06
Latest Date of Registration : 2007-07-06
Japanese Pharmacopoeia Camostat Mesilate (for manufacturing only)
Registration Number : 218MF10465
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2006-04-27
Latest Date of Registration : 2006-04-27
Date of Issue : 2022-09-19
Valid Till : 2025-07-02
Written Confirmation Number : WC-0119
Address of the Firm : Plot No. 35, 36, 38, 39, 40, 49, 50 & 51, Phase-IV, IDA, Jeedimetla, Medchal-Mal...
Registrant Name : Daewoong Bio Co., Ltd.
Registration Date : 2021-09-17
Registration Number : 20210917-209-J-1107
Manufacturer Name : Daewoong Bio Co., Ltd.
Manufacturer Address : 29, Yakjedanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
Registrant Name : Grace Farm
Registration Date : 2021-03-31
Registration Number : 20210331-209-J-648
Manufacturer Name : Erregierre SpA
Manufacturer Address : Via F. Baracca, 19-24060 SAN PAOLO D'ARGON (BG), Italy
Registrant Name : Ilsung IS Co., Ltd.
Registration Date : 2021-04-02
Registration Number : 20210402-209-J-755
Manufacturer Name : Fuji Chemical Industries Co....
Manufacturer Address : 1 Gohkakizawa, Kamiichi-machi, Nakaniikawa-gun Toyama 930-0405 Japan
Registrant Name : MFC Corporation
Registration Date : 2021-07-05
Registration Number : 20210705-209-J-1054
Manufacturer Name : MFC Corporation
Manufacturer Address : 35 Cheongwon Industrial Complex 7-gil, Mado-myeon, Hwaseong-si, Gyeonggi-do
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...
About the Company : Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with...
About the Company : Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Fukangren no...
About the Company : ERREGIERRE, a family company, was founded in 1974 and today is one of the leading Italian active pharmaceutical ingredients manufactures for human and veterinary use. In ERREGIE...
About the Company : Laurus Labs is a leading research and development-driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Ph...
About the Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Active Pharmaceutical Ing...
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
23
PharmaCompass offers a list of Camostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camostat manufacturer or Camostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camostat manufacturer or Camostat supplier.
PharmaCompass also assists you with knowing the Camostat API Price utilized in the formulation of products. Camostat API Price is not always fixed or binding as the Camostat Price is obtained through a variety of data sources. The Camostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Camostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camostat, including repackagers and relabelers. The FDA regulates Camostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Camostat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Camostat supplier is an individual or a company that provides Camostat active pharmaceutical ingredient (API) or Camostat finished formulations upon request. The Camostat suppliers may include Camostat API manufacturers, exporters, distributors and traders.
click here to find a list of Camostat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Camostat Drug Master File in Japan (Camostat JDMF) empowers Camostat API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Camostat JDMF during the approval evaluation for pharmaceutical products. At the time of Camostat JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Camostat suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Camostat Drug Master File in Korea (Camostat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Camostat. The MFDS reviews the Camostat KDMF as part of the drug registration process and uses the information provided in the Camostat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Camostat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Camostat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Camostat suppliers with KDMF on PharmaCompass.
A Camostat written confirmation (Camostat WC) is an official document issued by a regulatory agency to a Camostat manufacturer, verifying that the manufacturing facility of a Camostat active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Camostat APIs or Camostat finished pharmaceutical products to another nation, regulatory agencies frequently require a Camostat WC (written confirmation) as part of the regulatory process.
click here to find a list of Camostat suppliers with Written Confirmation (WC) on PharmaCompass.
Camostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Camostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Camostat GMP manufacturer or Camostat GMP API supplier for your needs.
A Camostat CoA (Certificate of Analysis) is a formal document that attests to Camostat's compliance with Camostat specifications and serves as a tool for batch-level quality control.
Camostat CoA mostly includes findings from lab analyses of a specific batch. For each Camostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Camostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Camostat EP), Camostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Camostat USP).